Related Experiment Video
Updated: Feb 2, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
Invasive Meningococcal Disease in the Vaccine Era
1Paediatric Intensive Care Unit, St. Mary's Hospital and Imperial College London, London, United Kingdom.
Abstract:
Infection with the meningococcus is one of the main causes of meningitis and septicaemia worldwide. Humans are the only natural reservoir for the meningococcus which is found primarily as a commensal inhabitant in the nasopharynx in ~10% of adults, and may be found in over 25% of individuals during adolescence. Prompt recognition of meningococcal infection and early aggressive treatment are essential in order to reduce mortality, which occurs in up to 10% of those with invasive meningococcal disease (IMD). This figure may be significantly higher in those with inadequate or delayed treatment. Early administration of effective parenteral antimicrobial therapy and prompt recognition and appropriate management of the complications of IMD, including circulatory shock and raised intracranial pressure (ICP), are critical to help improve patient outcome. This review summarizes clinical features of IMD and current treatment recommendations. We will discuss the evidence for immunization and effects of vaccine strategies, particularly following implementation of effective vaccines against Group B meningococcus.
Insights
Meningococcal infections cause meningitis and septicaemia globally. Prompt diagnosis and treatment, including effective vaccines, are crucial for reducing mortality from invasive meningococcal disease (IMD).
Area of Science:
- Microbiology
- Infectious Diseases
- Epidemiology
Background:
- Neisseria meningitidis (meningococcus) is a primary cause of meningitis and septicaemia worldwide.
- Humans are the sole reservoir, with asymptomatic nasopharyngeal carriage common in adolescents.
- Invasive meningococcal disease (IMD) has a significant mortality rate, especially with delayed treatment.
Purpose of the Study:
- To review the clinical features of IMD.
- To outline current treatment recommendations for IMD.
- To discuss the impact of immunization strategies, including Group B meningococcus vaccines.
Main Methods:
- Literature review of clinical features and treatment of IMD.
- Analysis of existing evidence on meningococcal vaccines.
- Discussion of epidemiological data on meningococcal carriage and disease.
Main Results:
- Early recognition and aggressive parenteral antimicrobial therapy are critical for improving outcomes in IMD.
- Management of complications like shock and raised intracranial pressure is essential.
- Vaccination strategies, particularly against Group B meningococcus, have shown significant effects.
Conclusions:
- Prompt and effective management, alongside vaccination, is key to reducing IMD mortality.
- Understanding meningococcal epidemiology and carriage is vital for public health interventions.
- Continued research and vaccine development are important for controlling meningococcal disease.
Related Concept Videos
Vaccinations
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Mechanical Ventilation II: Invasive Ventilation
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

